909122-27-6

Basic information

• Product Name: 1-Bromo-2-chloro-3-fluoro-4-methoxybenzene
• Synonyms: 1-Bromo-2-chloro-3-fluoro-4-methoxybenzene;4-Bromo-3-chloro-2-fluoroanisole
• CAS NO: 909122-27-6
• Molecular Formula: C7H5BrClFO
• Molecular Weight: 239.4694032
• Mol File: 909122-27-6.mol
• Article Data: 6

Chemical Properties

• Melting Point: 49-50℃
• Boiling Point: 261℃
• Flash Point: 112℃
• Appearance: /
• Density: 1.642
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Bromo-2-chloro-3-fluoro-4-methoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-2-chloro-3-fluoro-4-methoxybenzene(909122-27-6)
• EPA Substance Registry System: 1-Bromo-2-chloro-3-fluoro-4-methoxybenzene(909122-27-6)

Safety Data

• Hazardous Substances Data: 909122-27-6(Hazardous Substances Data)

Usage

Uses

1-Bromo-2-chloro-3-fluoro-4-methoxybenzene is a synthetic intermediate in the synthesis of liquid crystal compound.

Upstream product

• 261762-56-5 1-chloro-2-fluoro-3-methoxy-benzene 

Relevant articles and documents

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R11 are as described herein NA (I) and pharmaceutically acceptable salts thereof.5 Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

The invention provides novel imidazopyrazine derivatives having general formula (I), wherein R1 to R11 are as described herein, and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and related diseases.

IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein A and R1 to R14 are as described herein (I) and pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.